BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36630722)

  • 1. Port-Site Metastasis Identified on Prostate-Specific Membrane Antigen-Targeted 18 F-DCFPyL PET/CT After Robot-Assisted Laparoscopic Radical Prostatectomy.
    Zahed H; Laufer J; LeBlanc M; Tisseverasinghe S; Niazi T; Probst S
    Clin Nucl Med; 2023 Apr; 48(4):e186-e187. PubMed ID: 36630722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Port site and peritoneal metastasis following laparoscopic radical prostatectomy and salvage radiotherapy for prostate adenocarcinoma.
    Caño-Velasco J; Herranz-Amo F; Polanco Pujol L; Barbas-Bernardos G; Morelejo-Gárate M; Subirá-Ríos D; Hernández-Fernández C
    Arch Esp Urol; 2019 Nov; 72(9):974-977. PubMed ID: 31697261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic Port-Site Metastasis From Prostate Cancer on 18F-Fluciclovine PET/CT.
    Tran G; Parrinello D; Dalal I
    Clin Nucl Med; 2021 May; 46(5):e279-e281. PubMed ID: 33208626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Evaluation of PSMA-Targeted
    Rowe SP; Campbell SP; Mana-Ay M; Szabo Z; Allaf ME; Pienta KJ; Pomper MG; Ross AE; Gorin MA
    J Nucl Med; 2020 Jan; 61(1):58-61. PubMed ID: 31201249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of disease detection using [
    Koschel S; Taubman K; Sutherland T; Yap K; Chao M; Guerrieri M; Benson A; Starmans M; Byrne G; Ong G; Macleod C; Foo M; Wong LM; Gyomber D; Ng M
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3712-3722. PubMed ID: 33852051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer laparoscopic port site metastasis: A case report.
    Jundt MC; Broski SM
    Medicine (Baltimore); 2018 Dec; 97(51):e13757. PubMed ID: 30572522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer.
    Meijer D; Luiting HB; van Leeuwen PJ; Remmers S; Jansen BHE; Bodar YJL; Witteveen T; Schaake EE; van der Poel HG; Wondergem M; Busstra MB; Nieuwenhuijzen JA; Meijnen P; Brabander T; van Moorselaar RJA; Hendrikse NH; Oprea-Lager DE; Roobol MJ; Vis AN
    J Urol; 2021 Apr; 205(4):1100-1109. PubMed ID: 33207138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological predictors of
    Perry E; Talwar A; Taubman K; Ng M; Wong LM; Sutherland TR
    BJU Int; 2022 Jun; 130 Suppl 1(Suppl 1):28-36. PubMed ID: 35768883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of
    Mena E; Rowe SP; Shih JH; Lindenberg L; Turkbey B; Fourquet A; Lin FI; Adler S; Eclarinal P; McKinney YL; Citrin DE; Dahut W; Wood BJ; Chang R; Levy E; Merino M; Gorin MA; Pomper MG; Pinto PA; Eary JF; Choyke PL; Pienta KJ
    J Nucl Med; 2022 Aug; 63(8):1184-1190. PubMed ID: 34916246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of prostate cancer with
    Bodar YJL; Jansen BHE; van der Voorn JP; Zwezerijnen GJC; Meijer D; Nieuwenhuijzen JA; Boellaard R; Hendrikse NH; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
    World J Urol; 2021 Jul; 39(7):2439-2446. PubMed ID: 33079250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Management After
    Ng M; Guerrieri M; Wong LM; Taubman K; Sutherland T; Benson A; Byrne G; Koschel S; Yap K; Starmans M; Ong G; Macleod C; Foo M; Chao M
    J Nucl Med; 2022 Sep; 63(9):1343-1348. PubMed ID: 35058320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Evaluation of
    Song H; Harrison C; Duan H; Guja K; Hatami N; Franc BL; Moradi F; Aparici CM; Davidzon GA; Iagaru A
    J Nucl Med; 2020 Apr; 61(4):546-551. PubMed ID: 31628216
    [No Abstract]   [Full Text] [Related]  

  • 14. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.
    Gondoputro W; Scheltema MJ; Blazevski A; Doan P; Thompson JE; Amin A; Geboers B; Agrawal S; Siriwardana A; Van Leeuwen PJ; van Oosterom MN; Van Leeuwen FWB; Emmett L; Stricker PD
    J Nucl Med; 2022 Nov; 63(11):1659-1664. PubMed ID: 35241483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer.
    Meijer D; Eppinga WSC; Mohede RM; Vanneste BGL; Meijnen P; Meijer OWM; Daniels LA; van den Bergh RCN; Lont AP; Ettema RH; Oudshoorn FHK; van Leeuwen PJ; van der Poel HG; Donswijk ML; Oprea-Lager DE; Schaake EE; Vis AN
    Eur Urol Oncol; 2022 Apr; 5(2):146-152. PubMed ID: 35074282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with
    Pienta KJ; Gorin MA; Rowe SP; Carroll PR; Pouliot F; Probst S; Saperstein L; Preston MA; Alva AS; Patnaik A; Durack JC; Stambler N; Lin T; Jensen J; Wong V; Siegel BA; Morris MJ
    J Urol; 2021 Jul; 206(1):52-61. PubMed ID: 33634707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques.
    Rowe LS; Harmon S; Horn A; Shankavaram U; Roy S; Ning H; Lindenberg L; Mena E; Citrin DE; Choyke P; Turkbey B
    Radiat Oncol; 2021 Feb; 16(1):32. PubMed ID: 33568190
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yılmaz B; Şahin S; Ergül N; Çolakoğlu Y; Baytekin HF; Sökmen D; Tuğcu V; Taşçı Aİ; Çermik TF
    Ann Nucl Med; 2022 Jul; 36(7):597-609. PubMed ID: 35426599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
    Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY
    Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-defining
    Tissot S; Wynn J; Tran V; Farag M; Wong LM; Ng M
    BJU Int; 2023 Oct; 132(4):411-419. PubMed ID: 37216190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.